Adenovirus early region 1A (Ad E1A) is a multifunctional protein which is essential for adenovirusmediated transformation and oncogenesis. Whilst E1A is generally considered to exert its in¯uence on recipient cells through regulation of transcription it also increases the level of cellular p53 by increasing the protein halflife. With this in view, we have investigated the relationship of Ad E1A to the proteasome, which is normally responsible for degradation of p53. Here we have shown that both Ad5 and Ad12 E1A 12S and 13S proteins can be co-immunoprecipitated with proteasomes and that the larger Ad12 E1A protein binds strongly to at least three components of the 26S but not 20S proteasome. One of these interacting species has been identi®ed as mammalian SUG1, a proteasome regulatory component which also plays a role in the cell as a mediator of transcription. In vitro assays have demonstrated a direct interaction between Ad12 E1A 13S protein and mouse SUG1. Following infection of human cells with Ad5 wt and Ad5 mutants with lesions in the E1A gene it has been shown that human SUG1 can be co-immunoprecipitated with full-length E1A and with E1A carrying a deletion in conserved region 1 which is the region considered to be responsible for increased expression of p53. We have concluded therefore that Ad E1A binds strongly to SUG1 but that this interaction is not responsible for inhibition of proteasome activity. This is consistent with the observation that puri®ed Ad12 E1A inhibits the activity of the puri®ed 20S but not 26S proteasomes. We have also demonstrated that SUG1 can be co-immunoprecipitated with SV40 T and therefore we suggest that this may represent a common interaction of transforming proteins of DNA tumour viruses.
Introduction
There is an absolute requirement for expression of adenovirus early region 1A (Ad E1A) proteins for Admediated transformation of cells in culture (reviewed Boulanger and Blair, 1991; Bayley and Mymryk, 1994; Williams et al., 1995) . The Ad E1A transcription block can be translated to give two major proteins which are identical except for the presence of a 46 amino acid (in Ad5) or 31 amino acid (in Ad12) unique region located towards the C terminus of the larger molecule. Ad E1A is a nuclear phosphoprotein which impinges on the functioning of the recipient cell in a variety of ways (Bayley and Mymryk, 1994; Moran, 1994) . During viral infection it acts as a regulator of transcription of other viral genes (Jones, 1995) . Similarly, in the transformed cell E1A can play a role in the control of expression of a number of host cell genes. Additionally, Ad E1A initiates cell cycle progression driving quiescent cells into S phase (Braithwaite et al., 1985; Quinlan and Grodzicker, 1987; Grand et al., 1998a) , is capable of inhibiting dierentiation (Maruyama et al., 1987; Webster et al., 1988) and can induce apoptosis (Rao et al., 1992; Debbas and White, 1993) and cell immortalization in certain circumstances (Gallimore et al., 1985) . These eects generally result from the interaction of E1A with important cellular protein components, such as pRb and its homologues p107 and p130, p300, TBP (TATA binding protein) and ATF-2 (reviewed Moran 1994; Bayley and Mymryk, 1994; Jones, 1995) . The binding sites on E1A for these and other cellular proteins have been mapped in most cases to regions of E1A conserved between dierent virus serotypes (Moran and Mathews, 1987) . Thus, for example, E1A interacts with the pRb family through conserved regions 1 and 2 (CR1 and 2) (Whyte et al., 1989) , with TBP binding to CR3 (Lee et al., 1991; Horikoshi et al., 1991; Geisberg et al., 1994) and the C terminal binding protein binding to a short highly conserved region very close to the C terminus (Boyd et al., 1993) .
Whilst Ad E1A usually aects the level of protein expression by its action at the transcriptional level, it has recently been shown to increase the level of p53, in both infected and transfected cells, by increasing the half-life of the protein (Lowe and Ruley, 1993; Grand et al., 1994) . The region of Ad E1A responsible for the control of p53 expression has been mapped to CR1 and the N terminal sequence required for p300 binding (Querido et al., 1997; Chiou and White, 1997) . Normally the expression of p53 is regulated transcriptionally and through the action of the 26S proteasome (Schener et al., 1990; Ciechanover et al., 1994) . Thus, in primary cells the protein is targeted to the proteasome by ubiquitination and then rapidly degraded.
Proteasomes constitute the major non-lysosomal proteolytic machinery of the eukaryotic cell (reviewed Rivett, 1993; Coux et al., 1996) . The 20S proteasome is composed of a stack of four rings which are themselves made up of seven a and seven b subunits. These structures, which appear to be primarily involved in the generation of peptides for presentation by MHC class I molecules at the cell surface can interact with a 19S regulatory complex to form the full 26S proteasome which catalyses the ATP-dependent degradation of ubiquinated protein substrates (Varshavsky, 1997) . The 19S regulatory subunit comprises at least ®fteen dierent proteins, a number of which are ATPases or form part of the cellular transcriptional machinery .
Ad E1A could in¯uence this protein degradation pathway in a number of ways but as an initial study we have considered the possibility that it could be having a direct eect on proteasomal activity as has recently been reported for the HIV-1 Tat protein (Seeger et al., 1997) . We report here that both the Ad5 289 and 243a.a. and Ad12 266 and 235a.a. proteins can be immunoprecipitated in a complex with proteasomes from Ad transformed cells and that Ad12 E1A can bind to a number of speci®c proteasomal components. One of these proteins has been identi®ed as 45K human SUG1 (hSUG1), a regulatory component of the 26S proteasome and homologue of yeast SUG1 (Rubin et al., 1996) . In addition, we have shown interaction of SUG1 with Ad E1A following wt Ad infection. SUG1 is also bound by Ad E1A which carries a deletion in CR1, suggesting that this interaction is not responsible for the Ad E1A-mediated increase in p53 expression.
Results
As Ad E1A appears to exert a direct eect on the cellular mechanism regulating the degradation of p53 we have investigated a number of potential ways in which the viral protein could interact with proteasomes.
Direct binding of Ad E1A to proteasomal components
To examine whether Ad E1A can form stable complexes with proteasomal components, co-immunoprecipitation experiments were carried out. Thus, Ad5 E1 HEK 293 cells were lysed under`mild' or`stringent' conditions (see Materials and methods) and precipitated with antibodies which recognize proteasomal components. Immunoprecipitates were electrophoresed on 15% polyacrylamide gels in the presence of 8M urea but in the absence of SDS and Western blotted for Ad5 E1A. This protocol has previously been used for the detection of E1A in immunoprecipitates, since the viral proteins migrate relatively rapidly as they are of low molecular weight and low pI (Grand and Gallimore, 1984) . The immunoglobulin heavy chain, which would normally migrate in a similar position to E1A on a gel run in the presence of SDS is retarded. It can be seen from the data presented in Figure 1 Signi®cantly less but still detectable Ad E1A could be seen when the procedure was repeated using thè stringent' buer conditions ( Figure 1A , lane 3 and B, lane 3). Similar co-immunoprecipitation of Ad E1A with proteasomes was seen with Ad2 E1A and Ad12 E1A-expressing cell lines (Ad2 E1A+N ras HER 313A and Ad12 E1 HER2 respectively, data not shown), indicating that the binding of E1A to proteasome components is not virus serotype speci®c.
The proteasome is a complex structure composed of many dierent subunits. In order to determine which of these might be involved in the binding to Ad E1A puri®ed rat liver 26S and 20S proteasomes and whole cell lysates were subjected to SDS polyacrylamide gel electrophoresis as outlined in Materials and methods. Proteins were transferred to nitrocellulose ®lters which were then incubated with puri®ed glutathione-Stransferase (GST) ± Ad12 E1A 266 amino acid fusion protein. After washing the ®lters, bound GST-E1A was detected with an antibody raised against the GST moiety. Figure 2A shows that Ad12 E1A interacted predominantly with proteins of molecular weight about 45.5K, 51.3K and 61.5K in puri®ed 26S proteasomes (lane 5). On longer exposures of the autoradiographs other E1A binding proteins of 31.8K, 43.6K and 86K molecular weight can be seen (lane 6). No binding of E1A to 20S proteasome components could be seen even on long exposures (lane 7). The major E1A binding proteins detected in the whole cell lysates, using this approach, were of about 30-35K ( Figure 2A , Figure 1 Co-immunoprecipitation of Ad5 E1A with mammalian proteasomes. Ad5 E1 HEK 293 cells were solubilized under`mild' (A, lane 2 and B, lane 2) or`stringent' conditions (A, lanes 1 and 3 and B, lanes 1 and 3) and immunoprecipitated with a rabbit polyclonal (pAb186) (A, lanes 2 and 3), or mouse monoclonal (Mab 20) (B, lanes 2 and 3) against mammalian proteasome components or an irrelevant antibody against HPV1 E4 (lane 1 in each panel). After PAGE in the absence of SDS (as described in the Materials and methods) samples were subjected to Western blotting using an antibody against Ad5 E1A. B, lane 4 Ad5 E1 HEK 293 whole cell lysate as a positive control for Ad E1A. Bands attributable to the two E1A components and IgG are indicated. (The slight dierence in mobility between immunoprecipitated E1A in lanes 2 and 3 and control E1A in lane 4 is due to the presence of residual immunoprecipitation wash buer in lanes 2 and 3) lanes 1 ± 4). We presume that the proteasomalinteracting species in these lysates were not detected because they were generally present at too low concentration. When a blot similar to that shown in Figure 2A was incubated with GST only (i.e. containing no E1A moiety) no binding to proteasome components could be observed ( Figure 2B , lanes 5 and 6). Some interaction could be observed between GST and high molecular weight proteins in the whole cell lysates ( Figure 2B , lanes 1 ± 4) after long exposures of the autoradiograph. Why these interactions between GST and cell components were not seen with GST-E1A (Figure 2A) is not apparent. No interactions could be seen in control blots which were incubated only in antibodies with no initial exposure to GST-E1A (data not shown). We conclude, on the basis of these data, that Ad E1A interacts with one or more of the regulatory proteins present in the 26S but not the 20S proteasome.
Ad E1A binds to SUG1
It can be seen from the data presented in Figure 2 that one of the major E1A binding proteins in the puri®ed 26S proteasomes is of 45K molecular weight. It has recently been reported that the proteasomal regulatory component mouse SUG1 (mSUG1) which is of similar molecular weight will bind to the immediate early gene product c-Fos (Wang et al., 1996) , TBP and nuclear receptors such as those for thyroid hormone (Lee et al., 1995) . With this in mind, a possible interaction of Ad E1A with hSUG1 was investigated. When lysates from Ad5 E1, Ad2
E1A+mutant ras and Ad12 E1 transformed cell lines were immunoprecipitated with an antibody against hSUG1, Ad E1A could be detected as a coprecipitating protein ( Figure 3A , lanes 2 and 3; B, lane 2 respectively). These immunoprecipitation experiments were performed in the presence of high concentrations of detergent (1% NP40) and salt (0.8 M NaCl) ± conditions which are likely to disrupt the 26S proteasome complex. The complementary experiment was also performed. Ad5 E1A was immunoprecipitated from an Ad5 E1 HEK293 cell lysate with the monoclonal antibody M58. After PAGE hSUG1 could be detected as a co-immunoprecipitating protein ( Figure 3C ). The results presented in Figure 3 clearly show that E1A form Ad5 E1 HEK 293 cells, Ad2 E1A+ras HER 313A and Ad12 E1 HER 2 cells forms a complex with hSUG1. We conclude that these results are indicative of direct interaction between Ad E1A and hSUG1 rather than co-precipitation of Ad E1A with the intact proteasome as shown in Figure  1 .
To con®rm this suggestion the binding of Ad12 E1A to mSUG1 in isolation was examined. Thus, various concentrations of puri®ed GST-mSUG1 fusion protein were immobilized on an ELISA plate (see Materials and methods). Ad12 E1A 266a.a. protein was added and then bound protein detected using the monoclonal antibody 5DO2 raised against Figure 2 Binding of Ad12 E1A to proteasome components. Whole cell lysates and puri®ed rat liver proteasomes were subjected to SDS ± PAGE and transferred to nitrocellulose membranes which were incubated with puri®ed GST-Ad12 E1A (A) or GST (B) as described in Materials and methods. Bound GST-Ad12 E1A or GST was detected using an antibody against the GST moiety. A Lane 1, Ad12 E1 HER 2 cells; 2, Ad5 E1 HEK 293 cells; 3, A549 cells; 4, A549 cells infected with Ad12 dl620; 5, puri®ed rat liver 26S proteasomes; 6, an overexposed copy of lane 5; 7, puri®ed rat liver 20S proteasomes. B lane 1, Ad12 E1 HER2 cells; 2 Ad5 E1 HEK 293 cells; 3, A549 cells; 4, Ad2 E1A+Nras HER 313A cells; 5, puri®ed rat liver 26S proteasomes; 6, puri®ed rat liver 20S proteasomes. Positions of molecular weight markers are shown Immunoprecipitated proteins were subjected to PAGE in the absence of SDS (as described in the Materials and methods) and Western blotting with a mouse monoclonal antibody against Ad5 E1A (A) or a rat tumour bearer serum against Ad12 E1A (B). Cell lines immunoprecipitated were: A, lanes 1 and 2. Ad5 E1 HEK 293 cells; lane 3, Ad2 E1A+Nras HER 313A cells; B, lanes 1 and 2: Ad12 E1 HER 2 cells. Bands attributable to the E1A proteins and IgG are indicated. C lysate from Ad5 E1 HEK 293 cells was solubilized under stringent conditions and immunoprecipitated with an irrelevant antibody against HPV1 E4 (lane 1) or a mouse monoclonal antibody against Ad5 E1A. After SDS ± PAGE and Western blotting hSUG1 was detected with a rabbit polyclonal antibody, as indicated. Bands attributable to IgG are indicated Ad12 E1A. It can be seen from the data presented in Figure 4 that E1A proteins bound to GST-mSUG1 but not to the GST-HPV1 E4 control. In addition, there was no interaction between GST-SUG1 and phosphorylatable myosin light chain (PLC) ± like Ad E1A a low molecular weight acidic protein (data not shown).
In vivo expression of hSUG1 and proteasome components in the presence of Ad E1A
Interaction with Ad E1 proteins can aect the level of expression, subcellular localization and activity of cellular polypeptides. For example, when p53 binds to Ad5 E1B 58K protein its expression is dramatically increased but this additional protein is largely inactive. Furthermore, p53 is present in cytoplasmic aggregates in Ad5 E1 transformed cells rather than in the nucleus (Zantema et al., 1985; Grand et al., 1996) . With this in view the eect of Ad E1A on the expression and localization of SUG1 and other proteasomal components has been investigated. The level of expression of SUG1 and a representative 20S proteasome component (p32, Peters et al., 1994) in tumour cells, Ad-transformed cells and cells infected with a mutant adenovirus expressing E1A were determined. It can be seen ( Figure 5A ) that there was virtually no dierence in the expression of hSUG1 in cells expressing Ad E1A (either as a result of DNA transfection [lanes 1 and 2] or viral infection [lane 4]) or not (lanes 3 and 5). There was rather more variation in the level of the p32 proteasome component ( Figure 5B ) but this did not appear to be dependent on adenovirus protein expression. Thus, p32 expression was low in Ad12 E1 HER 2 cells but appreciably higher in Ad5 E1 HEK 293 cells (lanes 1 and 2). Infection with Ad12 dl620 (which essentially only expresses E1A protein, Grand et al., 1994 ) caused some decrease in p32 level (compare lanes 3 and 4) but it is not clear that this reduction is signi®cant as much lower expression of p32 was apparent in KB tumour cells (lane 5). The Western blot shown in Figure 2C con®rms high levels of SUG1 in the 26S proteasome preparation shown in Figure 2 with appreciably less in the whole cell lysates and virtually none in the 20S proteasome preparation ( Figure 5C ). Figure 5D shows the total protein composition of 26S and 20S proteasomes.
Localisation of hSUG1
hSUG1 is a multifunctional protein which has been reported to be involved in many cellular processes beside proteasomal degradation (vom Baur et al., 1995; Lee et al., 1995; Fraser et al., 1997) . With this in view, we compared its subcellular localization with that of the proteasomes using immuno¯uorescence analysis. Cells stained with the antibody to mSUG1 showed strong nuclear¯uorescence and somewhat weaker cytoplasmic staining ( Figure 6A and C). Nuclear uorescence was not homogeneous, however, with strong punctate staining being apparent. Staining in Ad5 E1 HEK 293 cells (expressing Ad E1A) and A549 cells (no E1A) was comparable ( Figure 6A and C). When cells were stained with Mab20 (against the proteasome component) a similar, although not identical, pattern was observed ( Figure 6D ). Nuclear localization of hSUG1 and the proteasomes were similar although the cytoplasmic staining with Mab20 was somewhat weaker than that seen with the antibody against hSUG1 (Figure 6C and D) . Ad E1A can be seen to be located primarily in the nucleus of Ad5 E1 HEK 293 cells ( Figure 6B ), although the pattern of nuclear staining was not the same as that seen for either the proteasomes or SUG1.
Puri®ed Ad12 E1A inhibits proteasomal activity
In the studies described above we have established the interaction of Ad E1A with proteasome components. However, it is not clear how this binding aects proteasome activity. To address this point 26S and 20S proteasomes were isolated from rat liver and activities assayed using the peptide LLVY-NH-MCA as a substrate. The 266 amino acid (13S) component of Ad12 E1A was expressed in E. coli and puri®ed to homogeneity as described in Materials and methods. Increasing amounts of E1A were added to the proteasome assays. It can be seen from the data presented in Figure 7 that the viral protein inhibited the activity of the 20S proteasome but had little or no Figure 4 Binding of puri®ed Ad12 E1A to mSUG1. Various concentrations of puri®ed GST-mSUG1 or GST-HPV1 E4 were bound to an ELISA plate, which was then incubated with puri®ed Ad12 E1A 266a.a. proteins. Bound Ad12 E1A was detected using the monoclonal antibody 5DO2, as described in the Materials and methods. Absorbance due to bound Ad12 E1A is plotted against concentration of *, GST-mSUG1 or &, GST-HPV1 E4. Data shown are the mean of three determinations eect on the 26S proteasome. To con®rm that this inhibition was not due to competition by Ad E1A acting as a substrate, polyacrylamide gel electrophoresis of the assay mixtures was carried out. No degradation of Ad E1A was observed even after incubation for 2 h in the presence of rat liver proteasomes (data not shown). It is possible that inhibition of the activity of the 20S proteasome did not go to completion because Ad E1A was not binding at the active site. Veri®cation of this suggestion will, however, have to await further investigation. Figure 7 Eect of Ad12 E1A on proteasome activity. The activities of puri®ed rat liver 26S and 20S proteasomes were assayed in the presence of increasing concentrations of puri®ed Ad12 E1A 266a.a. protein using the peptide substrate LLVY-NH-MCA. Activities were calculated as a percentage of the activity in the absence of E1A. Each point is the mean of two separate determinations carried out in duplicate ÐÐ, 20S proteasome; ....., 26S proteasome Interaction of SUG1 with Ad E1A does not require CR1 or CR3
It has been established, by deletional analysis, that an intact conserved region 1 is necessary for Ad E1A to cause an increase in expression of p53 (Querido et al., 1997) . Therefore, it seemed reasonable to suppose that if the interaction of Ad E1A with SUG1 were responsible for modi®cation of proteasomal activity and ultimately an increase in p53 expression, Ad E1A with a deletion in CR1 would not bind to SUG1. To test this hypothesis A549 cells were infected with an Ad5 mutant virus expressing wt Ad E1A 243a.a. protein (Ad5 dl520) and a virus with an additional lesion in CR1 (Ad5 dl 1104/520). After 24 h cells were harvested and immunoprecipitated with an antibody against SUG1. Co-immunoprecipitated Ad5 E1A was detected by Western blotting after electrophoresis on polyacrylamide gels run in the presence of 8M urea as described above. The pattern of Ad E1A proteins expressed following viral infection is considerably more complex than that in E1-transformed cells (see for example, Harlow et al., 1985) . Thus, it can be seen that there are many more E1A components visible in lanes 1 and 2 in Figure 8 than in Figure 1 , lane 4 and Figure  3A , lane 3. However, it is apparent that the band attributable to the Ad5 E1A 243a.a. protein (con®rmed by co-electrophoresis with the protein present in Ad5 E1A transformed cells) is co-precipitated with SUG1. Data presented in Figure 8 show comparable levels of wt and mutant Ad5 E1A 243a.a. protein immunoprecipitated with SUG1. It is presumed that the two E1A bands seen in tracks 3 and 4 (Figure 8 ) are attributable to dierently charged (phosphorylated) forms of the protein. We conclude that the CR1 sequence does not encompass the binding site for SUG1. In addition, it is clear that Ad5 E1A CR3 is not required for Ad E1A/ SUG1 interaction as the viruses used in this series of experiments express only the lower molecular weight 243a.a. protein (which does not contain CR3). These data are consistent with the results shown in Figure 3 where the 289 and 243a.a. Ad5 E1A species were precipitated equally with antibodies against SUG1. Further studies are currently being carried out with a large panel of Ad E1A mutants (Mymryk and Bayley, 1993) to determine the precise binding site for SUG1.
SV40 T antigen binds to proteasomes and SUG1
Most of the interactions of E1A with cellular proteins are duplicated by SV40 T (see for example Fanning and Knippers, 1992) . Therefore to investigate whether this was true for SUG1 lysates from SV40 transformed cells (Cos1 and SVJD cells) were immunoprecipitated with antibodies raised against mammalian proteasomes and mSUG1. The bound proteins were subjected to Western blotting with an antibody against SV40T. Figure 9 clearly shows that SV40 T can be coimmunoprecipitated with antibodies against proteasome components and SUG1 under conditions which keep the 26S proteasome intact ( Figure 9A , lane 2 and B, lane 2) and under conditions which cause release of the 20S proteasome (lane 1 in both panels). However, there is considerably more SV40 T ag co-precipitated with Mab 20 (anti-proteasome antibody) when`mild' conditions are used, suggesting that the viral protein is predominantly bound to one or more components in the 19S regulatory complex, which is dissociated under stringent conditions. One of these regulatory components is SUG1. (No SV40T could be detected following immunoprecipitation with a control irrelevant antibody against HPV1 E4). However, it is important to note that when the complementary co-immunoprecipitation Figure 8 Co-immunoprecipitation of Ad5 E1A with hSUG1 following viral infection. A549 cells were infected with the viruses Ad5 dl520 and Ad 5 dl1104/520. After 24 h cells were solubilized under stringent conditions and hSUG1 immunoprecipitated using the rabbit polyclonal antibody. Immunoprecipated proteins were subjected to PAGE in the absence of SDS (as described in Materials and methods) and Western blotting using a monoclonal antibody against Ad5 E1A. Lane 1, whole cell lysate of A549 cells infected with Ad5 dl520; lane 2, whole cell lysate of A549 cells infected with Ad5 dl1104/520; lane 3 and 5, A549 cells infected with Ad5 dl520 and immunoprecipitated with an antibody against mSUG1 (lane 3) or an irrelevant antibody against HPV1 E4 (lane 5); lanes 4 and 6, A549 cells infected with Ad5 dl1104/520 immunoprecipitated with an antibody against mSUG1 (lane 4) or an irrelevant antibody against HPV1 E4 (lane 6). The major E1A component is indicated 1 and 2) . After SDS ± PAGE samples were subjected to Western blotting with antibodies against SV40 T ag (a rabbit antibody for A and a mouse monoclonal for B). Lane 3, in each case is a Cos-1 whole cell lysate. The position of migration of SV40 T ag and immunoglobulin heavy and light chains is shown experiment was carried out it was not possible to demonstrate complex formation. Thus, when cell lysates were immunoprecipitated with antibodies against SV40 T, no SUG1 could be detected after SDS ± PAGE and Western blotting. The implications of this are considered below.
Discussion
The changes in level of expression of p53 in Ad E1-expressing cells appear to be regulated primarily by changes in the half-life of the protein (Lowe and Ruley, 1993; Grand et al., 1994 Grand et al., , 1996 with no increase in the level of transcription of the gene in Ad E1 containing cells at least (Grand et al., 1993) . Both Ad E1A and the larger E1B protein can increase the half life of p53, apparently by quite separate mechanisms (Grand et al., 1996) . Thus, the E1B protein forms a strong complex with p53 presumably rendering it refractory to either ubiquitination or degradation by the proteasome. As E1A does not bind directly to p53, we considered that it might reduce proteolysis by interacting with, and inhibiting, the proteasome.
It has been shown here (Figures 1 and 2 ) that both the 13S and 12S Ad E1A proteins will bind strongly to various proteasomal components such that they will survive immunoprecipitation and/or washing in the presence of high concentrations of salt and non-ionic detergent. A number of interacting proteins within the 26S proteasome preparation can be seen (Figure 2 ) after incubation with GST-E1A which were not visible in control blots carried out with GST alone.
We calculated that one of the major E1A binding proteins had a molecular weight of 45K which approximated to the size of the 26S proteasome regulatory protein SUG1. In addition, we considered that SUG1 might be a target for E1A as it appears to be intimately involved in the regulation of transcription and interacts with cFos (Wang et al., 1996) . Thus, it can be seen from the data presented in Figure 3 that E1A can be co-immunoprecipitated with an antibody raised against mSUG1. To con®rm that this result was not simply due to co-precipitation of the intact proteasome with the mSUG1 antibody (although this would be very unlikely with the high detergent and salt concentrations used in the experiments), the binding of puri®ed Ad12 E1A 266 amino acid protein to puri®ed GST-mSUG1 was demonstrated using ELISAs ( Figure  4 ). In addition, interaction of GST-mSUG with the puri®ed 235a.a. Ad12 E1A protein has also been shown.
We conclude on the basis of the data discussed here that Ad E1A binds strongly to several 26S proteasomal components, one of which has been identi®ed as hSUG1. Using puri®ed Ad12 E1A 266 amino acid protein we have also demonstrated that the viral protein can inhibit the activity of puri®ed 20S proteasomes (Figure 7) . Perhaps surprisingly in view of the demonstrated ability of Ad E1A to bind to hSUG1, which is likely to be a regulatory component of the 26S proteasome and not present in the 20S complex ( Figure 5C ), it has no eect on the activity of 26S proteasome directed against¯uorescent-labelled peptide substrates (Figure 7 ). There are a number of possible explanations for this, for example it is possible that E1A will only inhibit the activity of 26S proteasome directed against a correctly ubiquinated protein substrate (rather than the peptide substrate used here). Alternatively, it is possible that binding of Ad E1A to SUG1 is not responsible for the observed increase in p53 half life seen after transfection of Ad E1A or infection with certain mutant viruses (Lowe and Ruley, 1993; Grand et al., 1994) . Indeed, this suggestion is consistent with the data presented in Figure 8 where it has been shown that there is little dierence in the ability of Ad5 E1A wt 243a.a. protein and a mutant protein carrying a deletion in CR1 to interact with SUG1. It has previously been demonstrated that Ad E1A CR1 mutants have a reduced ability to stabilize p53 (Querido et al., 1997; Chiou and White, 1997 ). It appears, therefore, that the relationship of Ad E1A with the proteasome is more complex than we had, at ®rst, envisaged. E1A binds to at least four of the regulatory components of the 26S proteasome (SUG1 and three unidenti®ed proteins) although SUG1 and perhaps the other proteins as well may have quite distinct roles within the cell. It is possible that it is these other activities which are targeted by Ad E1A. However, there is no doubt that puri®ed Ad E1A can inhibit the activity of the 20S proteasome in vitro (Figure 7 ). Whether such an activity occurs in vivo remains to be established.
However, Ad E1A is not unique amongst viral proteins in having a complex relationship with the proteasome. For example, HTLV-1 Tax binds to HsN3 and HC9 components of the 20S proteasome potentiating anchorage of NF-kB1/p105 to the proteasome (Rousset et al., 1996) . Perhaps more relevantly, HIV-1 Tat inhibits the activity of the 20S proteasome (directed against peptide substrates) but potentiates the activity of 26S (against a ubiquinated protein substrate) (Seeger et al., 1997) . HIV-1 Tat also interacts with two proteins (Tat binding proteins TBP-1 and TBP-7) which are homologous to yeast SUG1 and MSS1 but are not identical to mammalian SUG1 (Ohana et al., 1993) . There are certain similarities between the modes of action of Tat and Ad E1A in that both appear to be primarily involved in transcriptional regulation but may also aect antigen processing and presentation. It is tempting to suggest that these latter activities may be attributable, at least in part to similar actions on the proteasome. In addition, it has recently been shown that the HPV 16 E7 oncoprotein which, like E1A, interacts with pRb also binds to the S4 subunit of the 26S proteasome, aecting its ATPase activity (Berezutskaya and Bagchi, 1997) .
It is now apparent that mammalian SUG1 has a large number of activities quite distinct from any role in the proteasome. These activities are mostly involved in the regulation of transcription in some way. For example, SUG1 (also called Trip1) can interact with nuclear hormone receptors and the basal transcriptional machinery (vom Baur et al., 1995; Lee et al., 1995) , thus serving as a transcriptional mediator. It also possesses DNA helicase activity (Fraser et al., 1997) and binds directly to TBP . As mentioned above, it is possible, therefore, that direct binding of Ad E1A to hSUG1 may be intended, from the viral point of view, to interfere with some of these other activities. A detailed analysis of the eect of E1A on the multiple roles of SUG1 is beyond the scope of this investigation but it has been shown that there is no change or only very slight down-regulation in the level of expression of SUG1 in response to E1A. Furthermore, immuno¯uorescence staining of Ad E1 transformed cells and tumor cells show that E1A has little eect on the subcellular localization of hSUG1 and that the majority of this protein co-localized with the proteasome (or at least with another proteasome component) (Figure 6 ). We suggest, therefore, that the majority of SUG1 is intimately associated with the proteasome and that this association or its level of expression is unaected by Ad E1A. Whilst most E1A is nuclear in Ad E1 transformed cells the pattern of staining is dissimilar to that seen for SUG1 (Figure 6 ) ± this is consistent with the fact that E1A can bind to many other nuclear proteins ± presumably only a relatively small proportion is involved in complexes with SUG1.
Previous studies have con®rmed that there is a shared mechanism of transformation attributable to the dierent DNA tumour viruses in that the transforming proteins tend to interact with the same cellular targets. The data presented in Figure 9 suggest that SV40T can similarly bind to SUG1. However, we have as yet been unable to demonstrate reciprocal co-precipitation of SUG1 after immunoprecipitation carried out using antibodies against SV40T. With this in mind we consider that these data should be treated as preliminary but possibly indicative of a highly conserved function which may be important for the viral life cycle as well as in transformation in vitro.
Materials and methods

Cell lines and viral infections
Ad5 E1 human embryo kidney (HEK) 293 cells and Ad12 E1 human embryo retinoblast (HER) 2 cells express Ad E1A and E1B proteins, whilst Ad2 E1A+N-ras HER 313A has been transformed with Ad2 E1A+mutant N-ras DNA. These cell lines were grown in DME buered with HEPES containing 2 mM glutamine and 8% FCS. A549 cells derive from a human small cell lung carcinoma and were infected with Ad5 dl1104/520, Ad5 dl520 and Ad12 dl620 at an infectivity of 100 p.f.u. per cell (for Ad5 viruses) and 200 p.f.u. per cell (for Ad12). Ad5 dl520 is a mutant virus which only expresses the 243a.a. E1A protein; Ad5 dl1104/ 520 is a second mutant based on the E1A 243a.a. only protein which carries an additional mutation such that the E1A expressed carries a deletion in CR1 (amino acids 48 ± 60) (Mymryk and Bayley, 1993) . Ad12 dl620 is a mutant virus with a lesion in the E1B gene and essentially only expresses E1A protein (Grand et al., 1994) . KB is a second tumour cell line deriving from a human epidermal carcinoma.
Proteasomes and enzyme assays
20S and 26S proteasomes were puri®ed from rat liver, as described previously (Rivett et al., 1994; Reidlinger et al., 1997) . Proteasome activities were assayed using the synthetic peptide substrates LLVY-NH-Mec, LSTR-NHMec or LLE-Napas described previously (Rivett et al., 1994) at ®nal concentrations of 40 mM and 400 mM respectively. 1.5 mg of proteasome was used per assay with varying concentrations of puri®ed Ad12 E1A.
Expression of Ad12 E1A
Adenovirus 12 early region 1A 266 amino acid and 235 amino acid proteins were expressed in E. coli, solubilized in 9M urea and puri®ed under denaturing conditions as reported previously (Grand et al., 1998b) . Protein was renatured by slow dialysis against 10 mM NH 4 HCO 3 , 0.1 mM b-mercaptoethanol.
Ad12 E1A DNA was cloned into pGEX-3X (Pharmacia), allowing expression of Ad12 E1A 266 amino acid protein as a fusion product coupled to glutathione-S-transferase (GST). Puri®cation was by standard procedures using glutathioneagarose beads (Sigma). GST HPV1 E4 fusion protein and GST were also expressed in E. coli and puri®ed using a similar procedure.
Immunoprecipitation, polyacrylamide gel electrophoresis and Western blotting
Immunoprecipitation was performed under`stringent' and mild' conditions.`Stringent' conditions were essentially as described by Paraskeva et al. (1982) using buers containing 0.825 M NaCl and 1% NP40. Immunoprecipitation under`mild' conditions was carried out in the presence of 0.02% NP40, 5 mM ATP 10% glycerol and isotonic NaCl (Mason et al., 1998) . The latter conditions kept the 26S proteasome intact, whilst the former resulted in dissociation to give a 20S proteasome. For detection of E1A, immunoprecipitated proteins were solubilized in 9M urea, 50 mM Tris HCl pH 8, 0.15 M b-mercaptoethanol and were fractionated on 15% polyacrylamide gels run in the presence of 15 mM Tris 100 mM glycine 8M urea but in the absence of SDS. This system has two advantages in that it facilitates the separation of the larger and smaller E1A components and allows the separation of E1A from antibody heavy chain which would normally make impossible Western blotting with an antibody of the same species as that used in the immunoprecipitation reaction (Grand and Gallimore, 1984) .
For normal Western blotting, samples were electrophoresed on 12% polyacrylamide gels run in the presence of 0.1 M Tris, 0.1 M Bicine, 0.1% SDS. In all cases proteins were transferred electrophoretically to nitrocellulose ®lters which were processed using standard procedures.
When GST-E1A was used as a probe to detect interacting species, samples were fractionated by SDS ± PAGE and transferred to a nitrocellulose ®lter which was incubated in the presence of the fusion protein (2.5 mg/ml). Bound E1A was detected using an antibody against the GST moiety (1 : 2000, Pharmacia Biotech) followed by a peroxidase-linked anti-goat IgG and ECL reagent.
Binding of Ad12 E1A to mSUG1 using ELISA GST-mSUG1 (Wang et al., 1996) was expressed in E. coli and puri®ed using glutathione-agarose beads. Increasing concentrations (0 ± 10 mg per well) of puri®ed GST-mSUG1 protein were immobilized on microtitre plates (Nunc) at 48 overnight. Wells were blocked with 5% skimmed milk powder in PBS at 378 for 1 h. After washing with PBS containing 0.1% Tween (PBST) puri®ed Ad12 E1A 266a.a. was added (2.5 mg/well) and incubated at 378 for 1 h. Plates were washed (66) with PBST and bound E1A detected using the monoclonal antibody 5DO2 (200 ml/well of a 1 : 10 dilution), followed by HRP-linked anti-mouse IgG. HRP substrate (OPD) was added and the optical density measured at 405 nm using a BIO-TEK microtitre plate reader. Puri®ed GST-HPV1 E4 was also immobilized on the microtitre plate and binding of Ad12 E1A to it determined in a similar manner. In addition, the binding of myosin phosphorylatable light chain (PLC) to GSTmSUG1 was determined.
Immuno¯uorescence Cells were grown on glass multiwell slides and ®xed in acetone for 10 min at 7208. Slides were incubated in antibody (diluted in 20% heat inactivated goat serum) for 1 h at room temperature. Antigens were visualised by incubating in FITC labelled anti-species IgG.
Antibodies
Ad5 E1A was detected with the monoclonal antibody MT5 (PharMingen clone M58) diluted 1 : 2000 for Western blotting and 1 : 5 for immuno¯uorescence. Ad12 E1A was detected with a rat polyclonal tumour bearer serum (diluted 1 : 1000 for Western blotting) or the monoclonal antibody 5DO2 (Grand and Gallimore, unpublished data ± E1A epitope between amino acids 36 and 50). The 20S proteasome component p32 (Peters et al., 1994) was detected with a monoclonal antibody diluted 1 : 1000 for Western blotting (Progen). Proteasomes were immunoprecipitated with the monoclonal antibody Mab20 which recognises the C2 subunit (Kristensen et al., 1994) or with the rabbit polyclonal antibody pAb186 which recognises a number of components (Rivett and Sweeney, 1991) . Proteasomes were detected in immuno¯uorescence studies with Mab20 (diluted 1 : 5). hSUG1 was immunoprecipitated with a rabbit polyclonal antibody raised against a synthetic peptide (Wang et al., 1996) ; the same antibody was used to detect hSUG1 in Western blots (diluted 1 : 1000) and immuno¯uorescence studies (diluted 1 : 10). This rabbit antibody is speci®c for SUG1 in Western blots ( Figure 5 ) and in immuno¯ourescence experiments (data not shown). SV40 T antigen was detected with either a rabbit polyclonal (1 : 5000 for Western blots) ± a generous gift from Professor David Lane or mouse monoclonals (Pab 101 and Pab 108) (Santa Cruz).
